BerGenBio ASA (OSL: BGBIO)
10.90
-0.18 (-1.62%)
Aug 30, 2024, 4:25 PM CET
BerGenBio ASA Revenue
BerGenBio ASA had revenue of 521.00K NOK in the twelve months ending June 30, 2024, up 33.93% year-over-year. In the year 2023, BerGenBio ASA had annual revenue of 354.00K, down -9.00%.
Revenue (ttm)
521.00K
Revenue Growth
+33.93%
P/S Ratio
605.66
Revenue / Employee
34.73K
Employees
16
Market Cap
426.05M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 354.00K | -35.00K | -9.00% |
Dec 31, 2022 | 389.00K | -385.00K | -49.74% |
Dec 31, 2021 | 774.00K | 173.00K | 28.79% |
Dec 31, 2020 | 601.00K | -8.30M | -93.25% |
Dec 31, 2019 | 8.90M | 6.57M | 281.16% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Medistim ASA | 533.17M |
Nordhealth AS | 471.77M |
Nykode Therapeutics AS | 69.44M |
Photocure ASA | 513.58M |
Carasent ASA | 254.01M |
ArcticZymes Technologies ASA | 117.80M |
Hofseth BioCare ASA | 230.08M |
Gentian Diagnostics ASA | 151.51M |